OCUP Stock Price History and Quote Analysis: Insights for Investors

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own OCUP shares is N/A, representing N/A of the company's common stock.

BANK OF AMERICA CORP /DE/, in the last quarter, reduced its stake in OCUP by -100% restricting it's holding to 0 shares of worth nearly N/A. GROUP ONE TRADING, L.P. also lessened -100% of the OCUP shares from its portfolio, reducing its holding to 0 shares of worth N/A. VICTORY CAPITAL MANAGEMENT INC also shunned OCUP shares holding by -100% last quarter which brought its holding to 0 shares worth N/A.

As per its latest 13F filing, GEODE CAPITAL MANAGEMENT, LLC increased its stake in OCUP by 6.98% in the last quarter. The institutional holder raised its holding to 234.4 thousand shares having worth more than $471.25K. BRIDGEWAY CAPITAL MANAGEMENT, LLC also added 21.12% more shares of OCUP to its portfolio, raising its holding to 209.94 thousand shares of worth $421.98K. RENAISSANCE TECHNOLOGIES LLC also increased its OCUP shares holding by 458.51% which brought its holding to 135.3 thousand shares worth $272.00K.

The insider with the most stakes in OCUP is Ahn Chang Ho , director at the company. Additionally, OCUP stock is highly held by director Park Young Soon and Chief Financial Officer Jeong Tae Heum among others.

Company executives, directors, and other insiders own N/A percent of Ocuphire Pharma, Inc.'s stock. Within the last six months, there have been 0 transaction(s) in which OCUP insiders have sold stock, totaling 0 shares. Insiders that have sold shares include AHN CHANG HO, JEONG TAE HEUM, and PARK YOUNG SOON.

There have been 2 transaction(s) during the past 6-months in which Ocuphire Pharma, Inc. insiders have bought stock, totalling 8500 shares

Around 508.5K Ocuphire Pharma, Inc. shares are held by insiders, which represents about N/A of OCUP stock.

OCUP director, Ahn Chang Ho holds the largest portfolio of the company's shares. OCUP shares owned by Ahn total nearly 6.01 million.

BANK OF AMERICA CORP /DE/ is the largest institutional owner in OCUP which holds 0 shares worth N/A or 0% of the total OCUP shares outstanding followed by CARSONALLARIA WEALTH MANAGEMENT, LTD. with ownership of 1 thousand shares representing 0% of the OCUP ownership. GROUP ONE TRADING, L.P. is the third largest stakeholder with 0 shares or 0% of the ownership worth more than N/A.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the OCUP is concerned, it is a stock which is optionable.

Number of OCUP shares short is 1.03M. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, 26.20M shares of OCUP are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, OCUP has 24.52M shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for OCUP is 5.61.